Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt

• Main Authors: JP Sevilla (Author), Daria Burnes (Author), Rehab Zakaria El Saie (Author), Hammam Haridy (Author), Matt Wasserman (Author), Sarah Pugh (Author), Johnna Perdrizet (Author), David Bloom (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

New vaccine introductions (NVIs) raise issues of value for money (VfM) for self-financing middle-income countries like Egypt. We evaluate a pediatric pneumococcal conjugate vaccine (PCV) NVI in Egypt from health payer and societal perspectives, using cost-utility and cost-benefit analysis (CUA, CBA)...